| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |